Hypoplastic corpus callosum, hypotonia, intellectual disability, and hearing impairment were noted in some but not all patients carrying gain-of-function RAC1 mutations, requiring further examination of the specific or common molecular pathology of RAC1-associated neurodevelopmental disorder and SPPRS. This evidence concerns the gene RAC1 and neurodevelopmental disorder.